BTG3
Basic information
Region (hg38): 21:17593653-17612945
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BTG3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 15 | 16 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 15 | 1 | 0 |
Variants in BTG3
This is a list of pathogenic ClinVar variants found in the BTG3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-17594134-G-A | not specified | Uncertain significance (Dec 21, 2023) | ||
21-17594154-G-A | not specified | Uncertain significance (Apr 12, 2022) | ||
21-17594254-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
21-17594293-G-C | not specified | Uncertain significance (May 13, 2024) | ||
21-17594317-A-T | not specified | Uncertain significance (Jun 22, 2023) | ||
21-17598628-G-C | not specified | Uncertain significance (May 02, 2024) | ||
21-17598645-A-G | not specified | Uncertain significance (Feb 07, 2023) | ||
21-17598648-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
21-17598789-C-G | not specified | Uncertain significance (Mar 22, 2023) | ||
21-17604154-A-G | not specified | Uncertain significance (Jul 17, 2023) | ||
21-17604164-C-T | not specified | Uncertain significance (Mar 07, 2024) | ||
21-17604166-G-A | not specified | Likely benign (Jan 30, 2024) | ||
21-17604172-A-G | EBV-positive nodal T- and NK-cell lymphoma | Likely benign (-) | ||
21-17604199-T-C | not specified | Uncertain significance (Mar 10, 2025) | ||
21-17604214-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
21-17604228-G-T | not specified | Uncertain significance (Feb 20, 2025) | ||
21-17604257-A-G | not specified | Uncertain significance (Aug 09, 2021) | ||
21-17604876-A-G | not specified | Uncertain significance (Mar 22, 2023) | ||
21-17609083-T-C | not specified | Uncertain significance (Feb 08, 2025) | ||
21-17609107-G-A | not specified | Uncertain significance (Mar 05, 2025) | ||
21-17609117-A-C | not specified | Uncertain significance (Jul 19, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BTG3 | protein_coding | protein_coding | ENST00000339775 | 5 | 19295 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.916 | 0.0841 | 125739 | 0 | 5 | 125744 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.86 | 88 | 153 | 0.576 | 0.00000781 | 1934 |
Missense in Polyphen | 12 | 43.187 | 0.27786 | 542 | ||
Synonymous | 0.600 | 47 | 52.5 | 0.895 | 0.00000270 | 554 |
Loss of Function | 2.99 | 1 | 12.3 | 0.0810 | 6.51e-7 | 169 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000190 | 0.000185 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000881 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Overexpression impairs serum-induced cell cycle progression from the G0/G1 to S phase.;
- Pathway
- RNA degradation - Homo sapiens (human)
(Consensus)
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- loftool
- 0.112
- rvis_EVS
- -0.16
- rvis_percentile_EVS
- 41.25
Haploinsufficiency Scores
- pHI
- 0.467
- hipred
- N
- hipred_score
- 0.370
- ghis
- 0.564
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.802
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Btg3
- Phenotype
- respiratory system phenotype; skeleton phenotype; neoplasm;
Gene ontology
- Biological process
- negative regulation of cell population proliferation;negative regulation of mitotic cell cycle
- Cellular component
- nucleus;cytoplasm
- Molecular function
- protein binding